CausalSentinel

Protein Dossier — VEGFA (Vascular endothelial growth factor A, long form)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Body mass index (BMI) -0.00885 0.00344 0.01 Wald ratio 1 cis NA
Bulimia nervosa -0.0256 0.00997 0.0101 Wald ratio 1 cis NA
Diagnoses - main ICD10: R07 Pain in throat and chest -0.0396 0.016 0.0131 Wald ratio 1 cis NA
Non-cancer illness code self-reported: uterine fibroids 0.0636 0.0261 0.0147 Wald ratio 1 cis NA
Diagnoses - main ICD10: R11 Nausea and vomiting -0.153 0.0641 0.0167 Wald ratio 1 cis NA
Knee and hip osteoarthritis 0.073 0.0306 0.017 Wald ratio 1 cis NA
Neo-agreeableness 0.219 0.092 0.0173 Wald ratio 1 cis NA
Haemoglobin concentration 0.0209 0.00883 0.0177 Wald ratio 1 cis NA
Birth length 0.0322 0.015 0.0314 Wald ratio 1 cis NA
Fractured bone site(s): Other bones 0.0309 0.0145 0.033 Wald ratio 1 cis NA
Coronary heart disease -0.0279 0.0135 0.0388 Wald ratio 1 cis NA
Non-cancer illness code self-reported: vaginal prolapse or uterine prolapse 0.087 0.0428 0.042 Wald ratio 1 cis NA
…and 100 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2597_8_3 VEGF Suhre K 2019
prot-c-4867_15_2 VEGF121 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

1384 association rows across 677 traits (1328 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Thyroid stimulating hormone levels 1e-336 rs2396083 7 GCST90572789 no MR -> candidate analysis
Waist-to-hip ratio adjusted for BMI 3e-168 rs998584 43 GCST008733 no MR -> candidate analysis
Triglyceride levels 8e-159 rs998584 26 GCST90239661 no MR -> candidate analysis
high density lipoprotein cholesterol (HDLC, mean, inv-norm t 2e-145 rs998584 3 GCST90475352 no MR -> candidate analysis
Waist-hip ratio 3e-145 rs998584 17 GCST007067 no MR -> candidate analysis
triglyceride (mean, inv-norm transformed) 3e-144 rs998584 3 GCST90476435 no MR -> candidate analysis
Waist-hip index 7e-138 rs998584 18 GCST90020027 no MR -> candidate analysis
A body shape index 6e-129 rs998584 16 GCST90020024 no MR -> candidate analysis
high density lipoprotein cholesterol (HDLC, minimm, inv-norm 9e-129 rs998584 3 GCST90475356 no MR -> candidate analysis
triglyceride (maximum, inv-norm transformed) 7e-127 rs998584 2 GCST90476431 no MR -> candidate analysis
high density lipoprotein cholesterol (HDLC, maximum, inv-nor 8e-126 rs998584 3 GCST90475348 no MR -> candidate analysis
Cholesteryl Esters in Large HDL 2e-123 rs998584 2 GCST90501136 no MR -> candidate analysis
…and 665 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 6064 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
diabetic retinopathy 0.069 common-variant locus no MR -> candidate analysis
wet macular degeneration 0.068 common-variant locus no MR -> candidate analysis
breast cancer 0.056 common-variant locus MR: beta=0.0242, p=0.184 (cis)
macular degeneration 0.078 common-variant locus no MR -> candidate analysis

Of the 4 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 13 known modulators (Vascular endothelial growth factor A, long form)
gnomAD constraint pLI=0.4, LOEUF=0.585 — LoF-tolerant
GWAS Catalog 122 unique SNPs / 294 rows
ClinVar 126 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx 28 clinical annotations across 17 drugs

Caveats declared by the tools

Sources

Provenance